High-grade cervical intraepithelial neoplasia, human papillomavirus and factors connected with recurrence following surgical treatment

Clinical and Experimental Obstetrics and Gynecology

Volumn 35, Issue 4, 2008, Pages 242-

  Ramos, M C ^a   De Lorenzo, B H Pizarro ^a   Michelin, M A ^a   Murta, Eddie F C ^a  

^a FEDERAL UNIVERSITY OF TRIÂNGULO MINEIRO   (Brazil)

Author keywords

Cervical intraepithelial neoplasia; Conization; Human papillomavirus; Immunological response; Recurrence

Indexed keywords

ADAPTIVE IMMUNITY; CANCER INVASION; CANCER RISK; CANCER STAGING; CANCER SURGERY; CAUSAL ATTRIBUTION; DISEASE SEVERITY; GENETIC DISORDER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLAMMATION; INNATE IMMUNITY; INVASIVE CARCINOMA; MITOSIS RATE; NONHUMAN; PERSISTENT INFECTION; POSTOPERATIVE COMPLICATION; RECURRENCE RISK; RECURRENT CANCER; REVIEW; RISK FACTOR; SMOKING; SURGICAL TECHNIQUE; TREATMENT FAILURE; TREATMENT OUTCOME; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CONIZATION; VIRUS CARCINOGENESIS; VIRUS LOAD; WART VIRUS;

CERVICAL INTRAEPITHELIAL NEOPLASIA; CONIZATION; FEMALE; HIV INFECTIONS; HUMANS; NEOPLASM RECURRENCE, LOCAL; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 57849111868     PISSN: 03906663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (60)

1. Bosch F.X., de Sanjosé S.: "The epidemiology of human papillomavirus infection and cervical cancer". Dis. Markers, 2007, 23, 213.
2. Woodman C.B., Collins S.I., Young L.S.: "The natural history of cervical HPV infection: unresolved issues". Nat. Rev. Cancer, 2007, 7, 11.
3. Brasil, Ministério da Saúde. INCA: "Estimativas da incidência e mortalidade por câncer o Brasil-2008". Available at: .
4. Mandic A., Vujkov T.: "Human papillomavirus vaccine as a new way of preventing cervical cancer: a dream or the future?". Ann. Oncol., 2004, 15, 197.
5. Prétet J.L., Charlot J.F., Mougin C.: "Virological and carcinogenic aspects of HPV". Bull. Acad. Natl Med., 2007, 191, 611.
6. Muñoz N., Castellsagué X., de González A.B., Gissmann L.: "HPV in the etiology of human cancer". Vaccine, 2006, 24 (suppl. 3), S1.
7. Schiffman M., Castle P.E., Jeronimo J., Rodriguez A.C., Wacholder S.: "Human papillomavirus and cervical cancer". Lancet, 2007, 370, 890.
8. Burd E.M.: "Human papillomavirus and cervical cancer". Clin. Microbiol. Rev., 2003, 16, 1.
9. Muñoz N., Bosch F.X., de Sanjosé S., Herrero R., Castellsagué X., Shah K.V. et al.: "Epidemiologic classification of human papillomavirus types associated with cervical cancer". N. Engl. J. Med., 2003, 348, 518.
10. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V. et al.: "Human papillomavirus is a necessary cause of invasive cervical cancer worldwide". J. Pathol., 1999, 189, 12.
11. von Keyserling H., Kaufmann A.M., Schneider A.: "HPV testing in the follow-up after treatment of women with CIN". Gynecol. Oncol., 2007, 107 (Suppl. 1), S5.
12. Boulet G., Horvath C., Vanden Broeck D., Sahebali S., Bogers J.: "Human papillomavirus: E6 and E7 oncogenes". Int. J. Biochem. Cell. Biol., 2007, 39, 2006.
13. Zhou X.B., Xu N.Z.: "Current advances in the mechanic studies of human papillomavirus-induced oncogenesis". Zhongguo Yi Xue Ke Xue Yuan Xue Bao, 2007, 29, 673.
14. Baseman J.G., Koutsky L.A.: "The epidemiology of human papillomavirus infections". J. Clin. Virol., 2005, 32 (suppl. 1), S16.
15. Vetrano G., Lombardi G., Di Leone G., Parisi A., Scardamaglia P., Pate G. et al.: "Cervical intraepithelial neoplasia: risk factors for persistence and recurrence in adolescents". Eur. J. Gynaecol. Oncol., 2007, 28, 189.
16. Murta E.F.C., Neves Junior M.A., Sempionato L.R., Costa M.C., Maluf P.J.: "Vaginal intraepithelial neoplasia: clinical-therapeutic analysis of 33 cases". Arch. Gynecol. Obstet., 2005, 272, 261.
17. Aerssens A., Claeys P., Garcia A., Sturtewagen Y., Velasquez R., Vanden Broeck D. et al.: "Natural history and clearance of HPV after treatment of precancerous cervical lesions". Histopathology, 2008, 52, 381.
18. Nomelini R.S., Barcelos A.C., Michelin M.A., Adad S.J., Murta E.F.C.: "Utilization of human papillomavirus testing for cervical cancer prevention in a university hospital". Cad Saúde Pública, 2007, 23, 1309.
19. Murta E.F.C., de Andrade F.C., Adad S.J., de Souza H.: "Low-grade cervical squamous intraepithelial lesion during pregnancy: conservative antepartum management". Eur. J. Gynaecol. Oncol., 2004, 25, 600.
20. Murta E.F.C., de Souza F.H., de Souza M.A., Adad S.J.: "High-grade cervical squamous intraepithelial lesion during pregnancy". Tumori, 2002, 88, 246.
21. Mathevet P., Chemali E., Roy M., Dargent D.: "Long-term outcome of a randomized study comparing three techniques of conization: cold knife, laser, and LEEP". Eur. J. Obstet. Gynecol. Reprod. Biol., 2003, 106, 214.
22. Martin-Hirsch P.L., Paraskevaidis E., Kitchener H.: "Surgery for cervical intraepithelial neoplasia". Cochrane Database Syst. Rev., 2000, CD001318.
23. Pires M.A., Dias M., Oliveira C., De Oliveira H.M.: "Factors of recurrence of intraepithelial lesions of the uterine cervix". Acta Med. Port., 2000, 13, 259.
24. Kjaer S.K., van den Brule A.J., Paull G., Svare E.I., Sherman M.E., Thomsen B.L. et al.: "Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study". Br. Med. J., 2002, 325, 572.
25. Pinto A.P., Crum C.P.: "Natural history of cervical neoplasia: defining progression and its consequence". Clin. Obstet. Gynecol., 2000, 43, 352.
26. Song S.H., Lee J.K., Oh M.J., Hur J.Y, Na J.Y., Park Y.K. et al.: "Persistent HPV infection after conization in patients with negative margins". Gynecol. Oncol., 2006, 101, 418.
27. Park J.Y., Lee K.H., Dong S.M., Kang S., Park S.Y., Seo S.S.: "The association of pre-conization high-risk HPV load and the persistence of HPV infection and persistence/recurrence of cervical intraepithelial neoplasia after conization". Gynecol. Oncol., 2008, 108, 549.
28. Nobbenhuis M.A., Meijer C.J., van den Brule A.J., Rozendaal L., Voorhorst F.J., Risse E.K. et al.: "Addition of high-risk HPV testing improves the current guidelines on follow-up after treatment for cervical intraepithelial neoplasia". Br. J. Cancer, 2001, 84, 796.
29. Clavel C., Masure M., Levert M., Putaud I., Mangeonjean C., Lorenzato M. et al.: "Human papillomavirus detection by the hybrid capture II assay: a reliable test to select women with normal cervical smears at risk for developing cervical lesions". Diagn. Mol. Pathol., 2000, 9, 145.
30. Chao A., Lin C.T., Hsueh S., Chou H.H., Chang T.C., Chen M.Y. et al.: "Usefulness of human papillomavirus testing in the follow-up of patients with high-grade cervical intraepithelial neoplasia after conization". Am. J. Obstet. Gynecol., 2004, 190, 1046.
31. Bodner K., Bodner-Adler B., Wierrani F., Kimberger O., Denk C., Grünberger W.: "Is therapeutic conization sufficient to eliminate a high-risk HPV infection of the uterine cervix? A clinicopathological analysis". Anticancer Res., 2002, 22, 3733.
32. Nagai Y., Maehama T., Asato T., Kanazawa K.: "Persistence of human papillomavirus infection after therapeutic conization for CIN 3: is it an alarm for disease recurrence?". Gynecol. Oncol., 2000, 79, 294.
33. Kanamori Y., Kigawa J., Minagawa Y., Irie T., Oishi T., Itamochi H. et al.: "Residual disease and presence of human papillomavirus after conization". Oncology, 1998, 55, 517.
34. Bae J.H., Kim C.J., Park T.C., Namkoong S.E., Park J.S.: "Persistence of human papillomavirus as a predictor for treatment failure after loop electrosurgical excision procedure". Int. J. Gynecol. Cancer, 2007, 17, 1271.
35. Gök M., Coupé V.M., Berkhof J., Verheijen R.H., Helmerhorst T.J., Hogewoning C.J. et al.: "HPV16 and increased risk of recurrence after treatment for CIN". Gynecol. Oncol., 2007, 104, 273.
36. Cruickshank M.E., Sharp L., Chambers G., Smart L., Murray G.: "Persistent infection with human papillomavirus following the successful treatment of high grade cervical intraepithelial neoplasia". BJOG, 2002, 109, 579.
37. Murta E.F.C., Resende A.V., Souza M.A., Adad S.J., Salum R.: "Importance of surgical margins in conization for cervical intraepithelial neoplasia grade III". Arch. Gynecol. Obstet., 1999, 263, 42.
38. Murta E.F.C., Conti R., Rodovalho J., Barcelos A.C., Adad S.J., de Souza H.: "Outcome after treatment of high-grade squamous intraepithelial lesions: relation between colposcopically directed biopsy, conization and cervical loop excision". Eur. J. Gynaecol. Oncol., 2004, 25, 587.
39. Sarian L.O., Derchain S.F., Andrade L.A., Tambascia J., Morais S.S., Syrjänen K.J.: "HPV DNA test and Pap smear in detection of residual and recurrent disease following loop electrosurgical excision procedure of high-grade cervical intraepithelial neoplasia". Gynecol. Oncol., 2004, 94, 181.
40. Reich O., Lahousen M., Pickel H., Tamussino K., Winter R.: "Cervical intraepithelial neoplasia III: long-term follow-up after cold-knife conization with involved margins". Obstet. Gynecol., 2002, 99, 193.
41. Maluf P.J., Adad S.J., Murta E.F.C.: "Outcome after conization for cervical intraepithelial neoplasia grade III: relation with surgical margins, extension to the crypts and mitoses". Tumori, 2004, 90, 473.
42. Van Leeuwen A.M., Pieters W.J., Hollema H., Burger M.P: "Atypical mitotic figures and the mitotic index in cervical intraepithelial neoplasia". Virchows Arch., 1995, 427, 139.
43. Claas E.C., Quint W.G., Pieters W.J., Burger M.P., Oosterhuis W.J., Lindeman J.: "Human papillomavirus and the three group metaphase figure as markers of an increased risk for the development of cervical carcinoma". Am. J. Pathol., 1992, 140, 497.
44. Wright T.C. Jr., Koulos J., Schnoll F., Swanbeck J., Ellerbrock T.V., Chiasson M.A. et al.: "Cervical intraepithelial neoplasia in women infected with the human immunodeficiency virus: outcome after loop electrosurgical excision". Gynecol. Oncol., 1994, 55, 253.
45. Tate D.R., Anderson R.J.: "Recrudescence of cervical dysplasia among women who are infected with the human immunodeficiency virus: a case-control analysis". Am. J. Obstet. Gynecol., 2002, 186, 880.
46. Holowaty P., Miller A.B., Rohan T., To T.: "Natural history of dysplasia of the uterine cervix". J. Natl. Cancer Inst., 1999, 91, 252.
47. Terra A.P., Murta E.F.C., Maluf P.J., Caballero O.L., Brait M., Adad S.J.: "Aberrant promoter methylation can be useful as a marker of recurrent disease in patients with cervical intraepithelial neoplasia grade III". Tumori, 2007, 93, 572.
48. Villa L.L.: "Human papillomaviruses and cervical cancer". Adv. Cancer Res., 1997, 71, 321.
49. Yang X., Jin G., Nakao Y., Rahimtula M., Pater M.M., Pater A.: "Malignant transformation of HPV 16-immortalized human endo-cervical cells by cigarette smoke condensate and characterization of multistage carcinogenesis". Int. J. Cancer, 1996, 65, 338.
50. Verguts J., Bronselaer B., Donders G., Arbyn M., Van Eldere J., Drijkoningeni M. et al.: "Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation". BJOG, 2006, 113, 1303.
51. Costa S., De Simone P., Venturoli S., Cricca M., Zerbini M.L., Musiani M. et al.: "Factors predicting human papillomavirus clearance in cervical intraepithelial neoplasia lesions treated by conization". Gynecol. Oncol., 2003, 90, 358.
52. Abdul-Karim F.W., Nuñez C.: "Cervical intraepithelial neoplasia after conization: a study of 522 consecutive cervical cones". Obstet. Gynecol., 1985, 65, 77.
53. Nguyen H.H., Broker T.R., Chow L.T., Alvarez R.D., Vu H.L., Andrasi J. et al.: "Immune responses to human papillomavirus in genital tract of women with cervical cancer". Gynecol. Oncol., 2005, 96, 452.
54. Kanodia S., Fahey L.M., Kast W.M.: "Mechanisms used by human papillomaviruses to escape the host immune response". Curr. Cancer Drug. Targets, 2007, 7, 79.
55. Kobayashi A., Greenblatt R.M., Anastos K., Minkoff H., Massad L.S., Young M. et al.: "Functional attributes of mucosal immunity in cervical intraepithelial neoplasia and effects of HIV infection". Cancer Res., 2004, 64, 6766.
56. Pinzon-Charry A., Maxwell T., Prato S., Furnival C., Schmidt C., López J.A.: "HLA-DR+ immature cells exhibit reduced antigen-presenting cell function but respond to CD40 stimulation". Neoplasia, 2005, 7, 1123.
57. Davidson B., Goldberg I., Kopolovic J.: "Inflammatory response in cervical intraepithelial neoplasia and squamous cell carcinoma of the uterine cervix". Pathol. Res. Pract., 1997, 193, 491.
58. Fernandes P.C. Jr., Garcia C.B., Micheli D.C., Cunha F.Q., Murta E.F.C., Tavares-Murta B.M.: "Circulating neutrophils may play a role in the host response in cervical cancer". Int. J. Gynecol. Cancer, 2007, 17, 1068.
59. Hammes L.S., Tekmal R.R., Naud P., Edelweiss M.I., Kirma N., Valente P.T. et al.: "Macrophages, inflammation and risk of cervical intraepithelial neoplasia (CIN) progression-clinicopathological correlation". Gynecol. Oncol., 2007, 105, 157.
60. Maluf P.J., Michelin M.A., Etchebehere R.M., Adad S.J., Murta E.F.C.: "T lymphocytes (CD3) may participate in the recurrence of cervical intraepithelial neoplasia grade III". Arch. Gynecol. Obstet., 2008, 278, 525.